InspireMD Statistics
Total Valuation
InspireMD has a market cap or net worth of $40.38 million. The enterprise value is $12.98 million.
| Market Cap | 40.38M |
| Enterprise Value | 12.98M |
Important Dates
The last earnings date was Monday, August 17, 2026, before market open.
| Earnings Date | Aug 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
InspireMD has 46.49 million shares outstanding. The number of shares has increased by 63.52% in one year.
| Current Share Class | 46.49M |
| Shares Outstanding | 46.49M |
| Shares Change (YoY) | +63.52% |
| Shares Change (QoQ) | +1.02% |
| Owned by Insiders (%) | 16.59% |
| Owned by Institutions (%) | 19.65% |
| Float | 25.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.61 |
| Forward PS | 3.31 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.80, with a Debt / Equity ratio of 0.10.
| Current Ratio | 3.80 |
| Quick Ratio | 3.40 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -202.81% and return on invested capital (ROIC) is -115.02%.
| Return on Equity (ROE) | -202.81% |
| Return on Assets (ROA) | -85.85% |
| Return on Invested Capital (ROIC) | -115.02% |
| Return on Capital Employed (ROCE) | -153.04% |
| Weighted Average Cost of Capital (WACC) | 7.90% |
| Revenue Per Employee | $85,362 |
| Profits Per Employee | -$413,244 |
| Employee Count | 127 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 3.09 |
Taxes
In the past 12 months, InspireMD has paid $63,000 in taxes.
| Income Tax | 63,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.33% in the last 52 weeks. The beta is 0.77, so InspireMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -65.33% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 1.33 |
| Relative Strength Index (RSI) | 50.43 |
| Average Volume (20 Days) | 106,698 |
Short Selling Information
The latest short interest is 85,336, so 0.18% of the outstanding shares have been sold short.
| Short Interest | 85,336 |
| Short Previous Month | 87,281 |
| Short % of Shares Out | 0.18% |
| Short % of Float | 0.33% |
| Short Ratio (days to cover) | 1.35 |
Income Statement
In the last 12 months, InspireMD had revenue of $10.84 million and -$52.48 million in losses. Loss per share was -$0.65.
| Revenue | 10.84M |
| Gross Profit | 1.96M |
| Operating Income | -53.56M |
| Pretax Income | -52.42M |
| Net Income | -52.48M |
| EBITDA | -52.98M |
| EBIT | -53.56M |
| Loss Per Share | -$0.65 |
Balance Sheet
The company has $30.42 million in cash and $3.03 million in debt, with a net cash position of $27.40 million or $0.59 per share.
| Cash & Cash Equivalents | 30.42M |
| Total Debt | 3.03M |
| Net Cash | 27.40M |
| Net Cash Per Share | $0.59 |
| Equity (Book Value) | 31.51M |
| Book Value Per Share | 0.67 |
| Working Capital | 26.98M |
Cash Flow
In the last 12 months, operating cash flow was -$41.21 million and capital expenditures -$1.25 million, giving a free cash flow of -$42.46 million.
| Operating Cash Flow | -41.21M |
| Capital Expenditures | -1.25M |
| Depreciation & Amortization | 578,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -42.46M |
| FCF Per Share | -$0.91 |
Margins
| Gross Margin | 18.05% |
| Operating Margin | -494.03% |
| Pretax Margin | -483.53% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InspireMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -63.52% |
| Shareholder Yield | -63.52% |
| Earnings Yield | -133.99% |
| FCF Yield | -108.40% |
Analyst Forecast
The average price target for InspireMD is $3.33, which is 283.38% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.33 |
| Price Target Difference | 283.38% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 235.08% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 27, 2021. It was a reverse split with a ratio of 1:15.
| Last Split Date | Apr 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
InspireMD has an Altman Z-Score of -9.88 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.88 |
| Piotroski F-Score | 3 |